Ortiz-Mendiguren Diego, Crespo-Orta Ian, Miranda-Márquez Mark, Rivera-Bobe Nicole, San Vicente-Morales Glorivette
Internal Medicine, Veterans Affairs Caribbean Healthcare System, San Juan, PRI.
Hematology/Oncology, Veterans Affairs Caribbean Healthcare System, San Juan, PRI.
Cureus. 2024 Jul 27;16(7):e65488. doi: 10.7759/cureus.65488. eCollection 2024 Jul.
Drug-induced thrombocytopenia is a rare but significant adverse effect of certain medications, with the potential for severe bleeding, thrombosis, and death. This report discusses a rare case of severe thrombocytopenia induced by ceftaroline in a 69-year-old male with a history of atrial fibrillation on rivaroxaban and allergies to amoxicillin and sulfa drugs. Following the initiation of ceftaroline for left lower extremity purulent cellulitis, his platelet count dropped from 204,000 to 4,000 x 10³/μL within a day. Given the low platelet levels, anticoagulation therapy, and bleeding risk, immediate interventions and prompt recognition prevented major complications, highlighting the importance of recognizing drug-induced thrombocytopenia in clinical practice.
药物性血小板减少症是某些药物罕见但严重的不良反应,有导致严重出血、血栓形成和死亡的风险。本报告讨论了一例罕见病例,一名69岁男性,有房颤病史,正在服用利伐沙班,对阿莫西林和磺胺类药物过敏,因使用头孢洛林导致严重血小板减少症。在开始使用头孢洛林治疗左下肢脓性蜂窝织炎后,他的血小板计数在一天内从204,000降至4,000×10³/μL。鉴于血小板水平低、抗凝治疗及出血风险,及时干预和迅速识别预防了严重并发症,凸显了在临床实践中识别药物性血小板减少症的重要性。